Raelipskie Partnership Invests $38,000 in Aflac Incorporated (NYSE:AFL)

Raelipskie Partnership bought a new stake in Aflac Incorporated (NYSE:AFL) during the third quarter, Holdings Channel.com reports. The fund bought 340 shares of the financial services provider’s stock, valued at approximately $38,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Y.D. More Investments Ltd purchased a new position in shares of Aflac during the second quarter worth about $25,000. Darwin Wealth Management LLC acquired a new stake in shares of Aflac in the 3rd quarter valued at about $34,000. Covestor Ltd grew its stake in Aflac by 41.8% during the 3rd quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares during the last quarter. Kennebec Savings Bank acquired a new position in Aflac during the third quarter worth approximately $45,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in Aflac in the third quarter valued at approximately $51,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. Piper Sandler upped their target price on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Truist Financial raised their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. UBS Group upped their price objective on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, August 14th. Finally, Wells Fargo & Company boosted their target price on Aflac to $107.00 and gave the company a “hold” rating in a report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $98.73.

Aflac Stock Down 0.4 %

Shares of NYSE AFL opened at $107.31 on Monday. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $111.05 and a 200 day moving average price of $102.35. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50. The stock has a market capitalization of $59.61 billion, a price-to-earnings ratio of 16.16, a price-to-earnings-growth ratio of 2.16 and a beta of 0.97.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. The business had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The company’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.84 EPS. Equities research analysts anticipate that Aflac Incorporated will post 7.27 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a $0.58 dividend. This is a positive change from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. This represents a $2.32 annualized dividend and a yield of 2.16%. Aflac’s dividend payout ratio is 30.12%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.